Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review

SIMPLE SUMMARY: For decades, there has been no globally accepted neoadjuvant or adjuvant therapy in resectable biliary tract cancer. Based on the results of the BILCAP trial, adjuvant capecitabine has been widely regarded as standard adjuvant therapy. Focusing on the management of resectable biliary...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Yoo, Changhoon, Shin, Sang Hyun, Park, Joon-Oh, Kim, Kyu-Pyo, Jeong, Jae Ho, Ryoo, Baek-Yeol, Lee, Woohyung, Song, Ki-Byung, Hwang, Dae-Wook, Park, Jin-hong, Lee, Jae Hoon
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8037230/
https://ncbi.nlm.nih.gov/pubmed/33916008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071647
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki